|Disease Group:||Hematologic Disorder; Leukemia|
|Phase of Study:||Phase I/Phase II|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||PR104 will be administered primarily on an outpatient basis. PR104 may be |
administered as an inpatient based at the discretion of the treating
physician.The length of hospital stay is 1-2 days every 2-3 weeks during 3
cycles of induction.
|Supported By:||Proacta Inc.|
|Return Visit:||1-3 times weekly during induction courses (1-3), then weekly during |
consolidation courses (1-4) if administered at MDACC. If during the
consolidation courses the patients are followed by the local oncologist, they
must come to MDACC every 3 weeks.
|Home Care:||Supportive care only.|